Startseite Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga

  • Sabrina Pricl,
Veröffentlicht/Copyright: 1. Januar 2009
Veröffentlichen auch Sie bei De Gruyter Brill
Informationen für Autor*innen
European Journal of Nanomedicine
Aus der Zeitschrift European Journal of Nanomedicine Band 2 Heft 1

Published Online: 2009-01
Published in Print: 2009-01

©2011 by Walter de Gruyter GmbH & Co.

Artikel in diesem Heft

  1. Editorial: Nanomedicine: shaping the future of medicine
  2. Editorial: The 2nd European Clinical Nanomedicine Conference is ahead
  3. Unsolved Medical Problems: Unresolved Problems in Cardiovascular Medicine waiting for Nanomedical Solutions
  4. Technologies at Hand: Measuring the intrinsic nanomechanics of molecular interactions with microcantilever sensors
  5. Preclinical Nanomedicine: Fluorescence in Clinical Nanometrology: its Potential Role in Diabetes Research and Management
  6. Impressum
  7. Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga
  8. Implications of Nanomedicine: The Spiritualization of Science, Technology, and Education in a One-World Society
  9. Unsolved Medical Problems: Blood-brain barrier in neurodegenerative diseases: perspectives for Nanomedicine
  10. Clinical Nanomedicine: Nanomedical aproaches in Parkinson’s disease
https://doi.org/10.1515/EJNM.2009.2.1.22

Artikel in diesem Heft

  1. Editorial: Nanomedicine: shaping the future of medicine
  2. Editorial: The 2nd European Clinical Nanomedicine Conference is ahead
  3. Unsolved Medical Problems: Unresolved Problems in Cardiovascular Medicine waiting for Nanomedical Solutions
  4. Technologies at Hand: Measuring the intrinsic nanomechanics of molecular interactions with microcantilever sensors
  5. Preclinical Nanomedicine: Fluorescence in Clinical Nanometrology: its Potential Role in Diabetes Research and Management
  6. Impressum
  7. Technologies at Hand: Quo vadis, affinity? Clinical evidences and computer-assisted simulations in the Imatinib saga
  8. Implications of Nanomedicine: The Spiritualization of Science, Technology, and Education in a One-World Society
  9. Unsolved Medical Problems: Blood-brain barrier in neurodegenerative diseases: perspectives for Nanomedicine
  10. Clinical Nanomedicine: Nanomedical aproaches in Parkinson’s disease
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 15.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/EJNM.2009.2.1.22/html?lang=de
Button zum nach oben scrollen